Key Market Indicators
Austrian vaccination coverage for children aged one is projected to remain stable at 85% by 2028, maintaining the same rate observed in 2023. This consistency has been a hallmark of the Austrian market since 2005, showing no significant change in vaccination rates over this period. In contrast, a slight decline is anticipated in the vaccination coverage for children aged one. Projections indicate a drop from 84% in 2023 to 82% by 2028, translating to a 0.5 percentage point decrease annually. This trend has been evident since 1985, with the market experiencing a gradual decline of 0.2 points year on year. The import of vaccines into Austria is also expected to decrease. By 2028, vaccine imports are forecasted to fall to $63.2 million, down from $67.5 million in 2023, representing a 1.2% annual decline. This continues a trend seen since 1999, where demand for vaccines has decreased by 0.3% annually. Conversely, Austrian vaccine exports are on the rise. Exports are projected to reach $264.7 million by 2028, up from $240.2 million in 2023, growing at an average annual rate of 1.4%. This increase follows a long-term trend of a 0.8% annual rise since 1999. In 2023, Austria ranked 13th globally in vaccine exports, with Spain leading at $240.2 million. Belgium, the United Kingdom, and France held the second, third, and fourth positions, respectively.
